Cannabis Science Inc., an emerging pharmaceutical cannabis company, was pleased to announce this morning that it has signed an agreement with Leading Points Corp. to represent its products, services and initiatives to various government and military agencies. Leading Points is led by its founder who retains 20 years of service as an active duty commissioned officer to establish and secure mutually beneficial relationships between its clients and the military and government markets.

Leading Points Corporation, Founder and President, Retired Lieutenant Colonel Kevin Sullivan, stated, “We are in the process of rolling out a phased strategy that initially calls for Leading Points Corporation to work with key decision makers in the 14 U.S. States where the legislatures have approved the use of whole cannabis, the natural product, for medicinal use. Next, we will represent the company in respect to a number of federal initiatives and to insure that they are positioned

Today’s announcement by Strategic American Oil Corporation (OTCBB:SGCA) — an exploration and production company with operations in Texas, Oklahoma, Louisiana, and Illinois, continues the company’s dynamic exploration plans for the lucrative oil fields of Illinois

The CEO Radio Network is pleased to announce that it has posted an interview with Riggs Eckleberry, Chief Executive Officer of Origin Oil, Inc. (OTCBB:OOIL) on the www.ceoradionetwork.com.

Cannabis Science Inc. (OTCBB: CBIS), an emerging cannabis pharmaceutical company, is proud to report that its CEO, Dr. Robert Melamede, Ph.D., spoke yesterday at a Denver hearing in opposition to an attempt to undermine a voter-approved constitutional amendment allowing the use of marijuana for medical purposes.

EcoBlu Products, Inc. and N8 Concepts, Inc. (OTCBB: NECO) announced today that they have been providing EcoBlu coating services to TUFF SHED, Inc. for use in their outdoor storage buildings, garages and custom building. TUFF SHED, Inc. is the largest manufacturer and installer

Cannabis Science Inc. is an emerging cannabis pharmaceutical company. Trading on the OTCBB, they are at the forefront of medical marijuana research and development. With headquarters in San Francisco, California, the company works with world authorities on phytocannabinoid science targeting critical illnesses. Phytocannabinoids - also called natural cannabinoids, herbal cannabinoids, and classical cannabinoids - are only known to occur naturally in significant quantity in the cannabis plant. They are concentrated in a viscous resin produced in glandular structures known as trichomes and are most prevalent in the flowers of the female plants.

Cannabis Science, Inc.’s dedication is to the creation of cannabis-based medicines. The company adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. They are working to create these medicines both with and without psychoactive properties as well as treat disease and the symptoms of disease

Last month, Cannabis Science reported that patent filings are expected for